miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential

• Autori principali: Hang Yan (Autore), Shengjie Tang (Autore), Shoujun Tang (Autore), Jun Zhang (Autore), Haiyang Guo (Autore), Chao Qin (Autore), Haiyang Hu (Autore), Chuan Zhong (Autore), Li Yang (Autore), Yunhe Zhu (Autore), Haining Zhou (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Non-small cell lung cancer (NSCLC) is one of the most common malignant tumors worldwide. Clinical success is suboptimal owing to late diagnosis, limited treatment options, high recurrence rates, and the development of drug resistance. MicroRNAs (miRNAs), a range of small endogenous non-coding RNAs t...